Patents by Inventor Claude H. Nash, III

Claude H. Nash, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anthracycline antibiotics produced by streptosporangium fragile
    Patent number: 4385122
    Abstract: A novel anthracycline antibiotic complex, fragilomycin complex, is produced by the cultivation of a fermentation broth containing Streptosporangium fragile Shearer sp. nov. ATCC 31519 microorganisms in an aqueous nutrient medium under submerged aerobic conditions. The fragilomycin complex and its major bioactive component, fragilomycin A, exhibit antibiotic activity.
    Type: Grant
    Filed: August 21, 1981
    Date of Patent: May 24, 1983
    Assignee: SmithKline Beckman Corporation
    Inventors: Claude H. Nash, III, Marcia C. Shearer, Kenneth M. Snader, Joseph R. Valenta, David Cooper
  • Anthracycline antibiotics produced by Streptosporangium fragilis Shearer sp. nov. ATCC 31519
    Patent number: 4293546
    Abstract: A novel anthracycline antibiotic complex, fragilomycin complex, is produced by the cultivation of a fermentation broth containing Streptosporangium fragilis Shearer sp. nov. ATCC 31519 microorganisms in an aqueous nutrient medium under submerged aerobic conditions. The fragilomycin complex and its major bioactive component, fragilomycin A, exhibit antibiotic activity.
    Type: Grant
    Filed: July 24, 1980
    Date of Patent: October 6, 1981
    Assignee: SmithKline Corporation
    Inventors: Claude H. Nash, III, Marcia C. Shearer, Kenneth M. Snader, Joseph R. Valenta, David Cooper
  • Procedure for obtaining penicillium species mutants with improved ability to synthesize mycophenolic acid
    Patent number: 4115197
    Abstract: A procedure for efficiently obtaining higher mycophenolic-acid-producing mutants from mycophenolic-acid-producing strains of the genus Penicillium by selecting mutants which are resistant to polyene antibiotics.
    Type: Grant
    Filed: August 29, 1977
    Date of Patent: September 19, 1978
    Assignee: Eli Lilly and Company
    Inventors: Stephen W. Queener, Claude H. Nash, III